Prostatic Carcinoma

Abstract

EACH year there are 42,000 new cases of prostatic carcinoma in the United States,¹ and with 17,000 deaths per year, it is the second leading cause of cancer deaths among American men.² Despite these alarming statistics, it can be calculated that 30 per cent, or roughly 12,000, of the new cases are potentially curable when first discovered.* But it seems that treatment designed to cure patients of this disease is being provided to only a fraction of the potentially curable ones. Consider that one of the most active groups in the country engaged in urologic surgery and oncology attempts cure . . .